Skip to main content
Clinical Trials/ACTRN12612000862842
ACTRN12612000862842
Recruiting
Not Applicable

Effect of cooling in aerobic exercise on fatigue and physical performance for people with Multiple Sclerosis: A preliminary crossover trial

Chris Barr0 sites60 target enrollmentStarted: August 15, 2012Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
Chris Barr
Enrollment
60

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • MS Subjects fulfilling the following criteria will be eligible to participate in this study:
  • Definite diagnosis of MS;
  • Mild to moderate difficulty in ambulation with Expanded Disability Status Scale (EDSS) 2\.0 – 5\.0;
  • Able and agree to engage in maximal exercise test with minimal work load above 30 watts, which is the starting workload of graded incremental cycling test;
  • Able to walk independently;
  • Self\-report in problem with fatigue;
  • Able to understand instructions and give informed consent
  • Inclusion criteria for healthy participants:
  • Healthy male or female
  • Over 18 years of age

Exclusion Criteria

  • The exclusion criteria include:
  • Use of medication prescribed for fatigue management (e.g Amantadine, Modafinil);
  • Currently participates in other clinical trials or exercise program;
  • Suffering from an exacerbation or relapse of MS within the past 3 months;
  • Severe depression;
  • Suffering form other neural, cardiovascular, orthopaedic or muscular disease besides MS;
  • Gastroesophageal disease or dysphagia which has difficulty in swallowing the disposable silicon\-coated pill to measure core temperature;
  • Diverticulitis, which is a digestive disease could affect bowel and become contraindication to pill ingestion;
  • Subject who is known to be pregnant;
  • Subject with blood clotting problem prone to bleeding complications in blood lactate testing;

Investigators

Sponsor
Chris Barr

Similar Trials